15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 12 of 15

 
 

Fresenius Medical Care (NYSE:FMS)

Consensus Rating
Hold
Rating Score
2.1
Ratings Breakdown
2 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$24.00 (13.0% Upside)

About Fresenius Medical Care

Fresenius Medical Care logoFresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/8/2024Morgan StanleyDowngradeEqual Weight ➝ Underweight
11/24/2023HSBCUpgradeReduce ➝ Hold
11/17/2023Societe GeneraleUpgradeHold ➝ Buy
10/11/2023Truist FinancialLower Price TargetHold ➝ Hold$28.00 ➝ $24.00
9/13/2023UBS GroupUpgradeSell ➝ Neutral
8/16/2023Morgan StanleyBoost Price Target€40.50
8/14/2023UBS GroupDowngradeBuy ➝ Neutral
8/1/2023CitigroupInitiated CoverageNeutral
7/13/2023Truist FinancialBoost Price TargetHold$26.00 ➝ $28.00
7/12/2023The Goldman Sachs GroupInitiated CoverageBuy
 

The asset beating inflation by 4x (Ad)

"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.

That's why we have released our Free Precious Metals Investment Guide that explains all the details